Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 593-598, Vol. 69, No. 1
Department of Microbiology, Immunology and
Molecular Genetics1 and Division of
Infectious Diseases, Department of Medicine,2
University of California School of Medicine, Los Angeles, California
90095
Received 10 August 2000/Returned for modification 20 September
2000/Accepted 20 October 2000
We have recently found that strain B31 infection-immune rabbits are
completely protected against homologous challenge with large numbers
(>106) of host-adapted Borrelia burgdorferi
(HAB) (E. S. Shang, C. I. Champion, X. Wu, J. T. Skare,
D. B. Blanco, J. N. Miller, and M. A. Lovett, Infect.
Immun. 68:4189-4199, 2000). In this study, we have extended these
findings to determine whether B31 strain infection-immune rabbits are
also protected against heterologous HAB challenge. Infection-immune
rabbits challenged with large numbers (>106) of homologous
HAB strain B31 were completely protected from erythema migrans (EM) and
skin and disseminated infection. In contrast, infection-immune rabbits
challenged with heterologous HAB strains N40 and Sh-2-82 were
completely susceptible to EM and skin and disseminated infection;
challenge with strain 297 also resulted in EM and infection of the skin
and viscera, but clearance of infection occurred 3 weeks postchallenge.
These findings confirm that immunity elicited in rabbits by B31 strain
infection confers complete protection against large-dose homologous HAB challenge but not against a heterologous strain.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.593-598.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Homologous and Heterologous Borrelia
burgdorferi Challenge of Infection-Derived Immune Rabbits Using
Host-Adapted Organisms
*
Corresponding authors. Mailing address: Department of
Microbiology and Immunology, UCLA School of Medicine, 10833 Le Conte Ave. CHS 43-239, Los Angeles, CA 90095. Phone: (310) 825-4188 or (310)
825-1979. Fax: (310) 267-2265. E-mail:
eshang{at}mednet.ucla.edu or
jmiller{at}microimmun.medsch.ucla.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|